Last reviewed · How we verify

NCT04368325

Low Creatinine Level and Respiratory Failure

Completed Last updated 29 April 2020
What this trial tests

trial testing Serum creatinine levels in Intensive Care Unit in 107 participants. Completed in 16 June 2017.

Timeline
17 May 2015
Primary endpoint
4 November 2016
16 June 2017

Quick facts

Lead sponsorOsijek University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment107
Start date17 May 2015
Primary completion4 November 2016
Estimated completion16 June 2017
Sites1 location across Croatia

Drugs / interventions tested

Conditions studied

Sponsor

Osijek University Hospital

Who can join

18 and older, any sex, with Intensive Care Unit or Respiratory Insufficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Low creatinine levels may be a sign of muscle atrophy or weakness, and therefore predictive for respiratory insufficiency in the Intensive care unit (ICU) patients. The investigators compared the outcomes of participants with low creatinine levels with subsequent ICU participants admitted into ICU in the tertiary hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Intensive Care Unit

Currently open trials in the same condition.

Other Osijek University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04368325.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing